Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes
Stock Information for Sernova Corp.
Loading
Please wait while we load your information from QuoteMedia.